| [1] |
Liu Q. Role of cytokinesin the pathophysiology of acute-on-chronic liver failure[J]. Blood Purif,2009,28(4):331-341.
|
| [2] |
Sarin SK, Kumar A, Almeida JA, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)[J]. Hepatol Int,2009,3(1):269-282.
URL
|
| [3] |
Ganem D, Prince AM. Hepatitis B virus infection--natural history and clinical consequences[J]. N Engl J Med,2004,350(11):1118-1129.
|
| [4] |
Sen S, Williams R, Jalan R. The pathophysiological basis of acute-on-chronic liver failure[J]. Liver,2002,22(Suppl 2):S5-S13.
|
| [5] |
汤伟亮，赵钢德，董志霞. 肝衰竭预后危险因素及预后模型建立的研究[J]. 传染病信息,2011,24(3):159-162.
|
| [6] |
唐克诚，李海，李谦, 等. 不同类型肝衰竭患者合并感染情况及对预后的影响[J]. 实用肝脏病杂志,2007,10(2):109-110.
|
| [7] |
李儒贵，占国清，谭华炳, 等. 肝衰竭合并细菌和真菌感染的特点及对预后的影响[J]. 湖北医药学院学报,2013,32(4):321-324.
|
| [8] |
European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis[J]. J Hepatol,2010,53(3):397-417.
URL
|
| [9] |
钟华平，周智，廖桂兰, 等. 肝硬化腹水并发结核性腹膜炎的预警指标分析[J]. 临床肝胆病杂志,2014,30(5):357-359.
|
| [10] |
Rocen M, Kieslichova E, Merta D, et al. The effect of Prometheus device on laboratory markers of inflammation and tissue regeneration in acute liver failure management[J]. Transplant Proc,2010,42(9):3606-3611.
|
| [11] |
庞国宏，马洪德，杨汝磊. 甲胎蛋白测定在重型肝炎预后的意义[J]. 中国医药指南,2010,8(6):85-86.
|
| [12] |
Du WB, Pan XP, Li LJ. Prognostic models for acute liver failure[J]. Hepatobiliary Pancreat Dis Int,2010,9(2):122-128.
URL
|
| [13] |
李金科，李云静，谢杏榕, 等. 肝康Ⅱ号对重型肝炎内毒素血症的影响[J/CD]. 中国肝脏病杂志:电子版,2014,6(2):53-55.
|
| [14] |
谭华炳，李刚，胡波, 等. 肝康Ⅱ号联合血浆置换治疗慢性肝衰竭临床分析[J]. 中国中医急症杂志,2011,20(8):1223-1225.
|
| [15] |
胡波，李儒贵，李金科, 等. 亚急性肝衰竭,肝硬化结节恩替卡韦联合肝康Ⅱ号治疗结节消失1例[J/CD]. 中国肝脏病杂志:电子版,2012,4(2):28-30.
|